| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12016-008-8112-Z |
| P698 | PubMed publication ID | 19048414 |
| P50 | author | Maria G Tektonidou | Q57034988 |
| P2093 | author name string | Maria G Tektonidou | |
| P2860 | cites work | The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients | Q28219758 |
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives | Q28324785 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Primary antiphospholipid syndrome with multiorgan arterial and venous thromboses | Q33354162 | ||
| Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study | Q33356515 | ||
| Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis | Q33358476 | ||
| A "primary" antiphospholipid syndrome? | Q79153146 | ||
| Catastrophic antiphospholipid syndrome in a 14-year-old child | Q81412262 | ||
| Catastrophic antiphospholipid antibody syndrome | Q81692089 | ||
| Kidney disease associated with primary antiphospholipid syndrome: clinical signs and histopathological features in an case experience of five cases | Q81858837 | ||
| Cerebral infarction in systemic lupus: association with anticardiolipin antibodies | Q93855660 | ||
| Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome | Q33359608 | ||
| Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. | Q33366482 | ||
| Significance of anti-phospholipid antibodies in patients with lupus nephritis | Q33373583 | ||
| Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis | Q33375135 | ||
| Addison's disease, hypertension, renal and hepatic microthrombosis in 'primary' antiphospholipid syndrome | Q33391137 | ||
| Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 | ||
| Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants | Q33458492 | ||
| The Prosser-White oration 1983. Connective tissue disease and the skin | Q33478362 | ||
| Fatal thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Relationship to circulating immune complexes | Q33485339 | ||
| Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients | Q33493550 | ||
| Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival | Q33501958 | ||
| Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies | Q33504040 | ||
| Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome | Q33562467 | ||
| Anticardiolipin antibodies and renovascular hypertension | Q33584068 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| The expanding spectrum of renal diseases associated with antiphospholipid syndrome | Q35140898 | ||
| Renal vein thrombosis in Chinese patients with systemic lupus erythematosus | Q35547446 | ||
| Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension | Q35552039 | ||
| Catastrophic antiphospholipid syndrome: where do we stand? | Q35607279 | ||
| Renal manifestations of the antiphospholipid syndrome. | Q36054845 | ||
| Antiphospholipid syndrome and the kidneys | Q36502421 | ||
| Pathogenic role of antiphospholipid antibodies | Q37168017 | ||
| Hypertension, renal artery stenosis and the "primary" antiphospholipid syndrome | Q39245962 | ||
| Raised concentrations of antibodies to cardiolipin in patients receiving dialysis | Q39930237 | ||
| Catastrophic secondary antiphospholipid syndrome with concomitant antithrombin III deficiency. | Q40450036 | ||
| The antiphospholipid syndrome: ten years on. | Q40711282 | ||
| Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies | Q40738058 | ||
| Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome. | Q40986119 | ||
| Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus | Q41705531 | ||
| Are antiphospholipid antibodies clinically relevant in dialysis patients? | Q42063764 | ||
| Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. | Q43829967 | ||
| Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease | Q44114961 | ||
| Glomerulonephritis in a patient with anticardiolipin antibody | Q44460505 | ||
| Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy | Q44641118 | ||
| Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome | Q44846963 | ||
| Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. | Q45034886 | ||
| Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation | Q45168730 | ||
| Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. | Q45215095 | ||
| Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both? | Q45238605 | ||
| Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). | Q45903801 | ||
| The long-term prognosis of renal transplantation in patients with lupus nephritis | Q46463548 | ||
| Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access | Q50144925 | ||
| Antiphospholipid (aPL) antibodies in end-stage renal disease. | Q50145488 | ||
| Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. | Q50870607 | ||
| Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. | Q52866849 | ||
| Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients | Q56907610 | ||
| Renal manifestations of the antiphospholipid syndrome | Q58622220 | ||
| Fibromuscular dysplasia of the renal arteries associated with antiphospholipid autoantibodies: two case reports | Q64997466 | ||
| Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure | Q67259233 | ||
| Renal involvement in primary antiphospholipid syndrome | Q67908661 | ||
| Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus | Q68026186 | ||
| The catastrophic antiphospholipid syndrome | Q68136491 | ||
| Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy | Q68348041 | ||
| Anti-cardiolipin antibody and renal disease: a report three cases | Q68398056 | ||
| Lupus glomerulonephritis with thrombotic microangiopathy | Q68861238 | ||
| Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant | Q69268396 | ||
| The anticardiolipin syndrome | Q69573545 | ||
| Accelerated hypertension associated with lupus anticoagulant and false-positive VDRL in systemic lupus erythematosus | Q70276972 | ||
| Lupus-like in vitro anticoagulant activity in end-stage renal disease | Q70391952 | ||
| Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant" | Q70518154 | ||
| Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Frequency and risk factors | Q71347972 | ||
| Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis | Q71517613 | ||
| Complete recovery from renal infarcts in a patient with mixed connective tissue disease | Q71775231 | ||
| Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis | Q71984959 | ||
| Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS) | Q72032541 | ||
| Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases | Q72046813 | ||
| Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance | Q72087634 | ||
| Captopril and aspirin in treatment of renal microangiopathy in primary antiphospholipid syndrome | Q72582704 | ||
| Hypertension and the antiphospholipid antibodies | Q72692336 | ||
| Renal vascular disease in patients with primary antiphospholipid antibodies | Q72759773 | ||
| Acute renal failure as first clinical manifestation of the primary antiphospholipid syndrome | Q72857213 | ||
| Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review | Q72883844 | ||
| Primary antiphospholipid antibody syndrome, renal infarction and hypertension | Q72922708 | ||
| Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect? | Q73314967 | ||
| Antiphospholipid syndrome and renal artery stenosis | Q73505498 | ||
| A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome | Q73540179 | ||
| Endstage renal failure in primary antiphospholipid syndrome--case report and review of literature | Q73817841 | ||
| Renovascular hypertension observed in a patient with antiphospholipid-antibody syndrome | Q74125091 | ||
| The intrarenal vascular lesions associated with primary antiphospholipid syndrome | Q74597824 | ||
| Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome | Q77484687 | ||
| Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients | Q77916198 | ||
| Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients | Q78043773 | ||
| Antiphospholipid antibodies are a risk factor for early renal allograft failure | Q78106843 | ||
| P433 | issue | 2-3 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 131-140 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy | |
| P478 | volume | 36 |
| Q33437339 | A 3-year follow-up of a patient with acute renal failure caused by thrombotic microangiopathy related to antiphospholipid syndrome: case report |
| Q59075500 | An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions |
| Q55177568 | Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment. |
| Q42167437 | Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis |
| Q33766670 | Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers |
| Q42732341 | Antiphospholipid syndrome-associated nephropathy: Current concepts |
| Q53747342 | Antiphospholipid syndrome-associated nephropathy; a nephropathy needs classification. |
| Q33419886 | Catastrophic APS in the context of other thrombotic microangiopathies |
| Q37476170 | Catastrophic antiphospholipid syndrome presented with sudden renal failure and history of long-lasting psychosis and hypertension in a 42 years old women |
| Q87393398 | Chapter 12: Lupus nephritis |
| Q46364902 | Coexistence of renal artery stenosis, primary antiphospholipid syndrome and polycythaemia vera: an exceptional association |
| Q41540102 | Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis |
| Q33421814 | Difficult clinical situations in the antiphospholipid syndrome |
| Q26741010 | Do we still need renal biopsy in lupus nephritis? |
| Q33396637 | Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation |
| Q34044464 | G alpha q-containing G proteins regulate B cell selection and survival and are required to prevent B cell-dependent autoimmunity |
| Q21284771 | Genome-wide association study of antiphospholipid antibodies |
| Q37736310 | Glomerular antibodies in lupus nephritis |
| Q41788311 | Hypertension and renal failure with right arm pulse weakness in a 65 years old man |
| Q36033553 | Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome |
| Q58754779 | Methimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of |
| Q33163886 | Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). |
| Q37476122 | Prevalence of anti- beta2GPI antibodies and their isotypes in patients with renal diseases and clinical suspicion of antiphospholipid syndrome |
| Q35521471 | Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report |
| Q57945954 | References |
| Q54967401 | Renal Involvement in Antiphospholipid Syndrome. |
| Q86984388 | Renal involvement in antiphospholipid syndrome |
| Q87467570 | Renal involvement in antiphospholipid syndrome |
| Q38838855 | Renal involvement in primary antiphospholipid syndrome |
| Q34590929 | Severe renal hemorrhage in a pregnant woman complicated with antiphospholipid syndrome: a case report |
| Q92017643 | Sex differences in clinical presentation of systemic lupus erythematosus |
| Q64951272 | Study of Antiphospholipid Antibodies in Patients with Arterial Hypertension. |
| Q36422203 | Successful Salvage of a Renal Allograft after Acute Renal Vein Thrombosis due to May-Thurner Syndrome |
| Q42843702 | The kidney biopsy in lupus nephritis: is it still relevant? |
| Q51640742 | Thrombolytic treatment in a patient with antiphospholipid syndrome : APS developing renal infarction. |
| Q33398993 | Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome |
| Q64388937 | Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus |
| Q86977898 | Ultrasonographic Evaluation of Resistive Index and Renal Artery Stenosis in Patients with Anti-Phospholipid Syndrome: Two Distinct Mechanisms? |
| Q48035289 | Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy? |
| Q26825218 | What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions? |
Search more.